LITTLE ROCK, Ark. (Arkansas Business) -- Stocks recovering some of their losses on Friday, which is a positive end to Wall Street's worst week in five months.
This, as Microsoft and Google both beat earnings expectations.
Shares of Microsoft gained 3 percent to $29.77, leading the Dow Jones industrial average higher. The software giant reported earnings late Thursday that beat analysts' forecasts and showed solid results from its Office, software tools and Xbox divisions.
Meanwhile, search leader Google's stock climbed 3 percent to $799.87. That company boosting prices for ads distributed to smartphones and tablet computers.
Big tech companies share earnings
And speaking of tech, this week will be a crucial one for other major tech firms.
Today we'll get earnings from streaming video leader Netflix. On Tuesday, AT&T and Apple will both report earnings.
And on Thursday, online retail leader Amazon will give its latest earnings report.
Gov. Beebe to sign legislature Monday
Here in Arkansas, a big day at the state Legislature.
Gov. Mike Beebe scheduled to sign legislation this morning that authorizes Arkansas to accept federal Medicaid funds and use them to buy private insurance for low-income residents.
The Legislature gave final approval to the plan Wednesday night.
Republican legislative leaders and Beebe, a Democrat, promoted the Medicaid "private option" plan as an alternative to expanding the state's Medicaid enrollment under the new federal health care law.
That debate was the centerpiece of this year's Legislative session. That session scheduled to wrap up tomorrow.
UAMS company plans to become publically traded
And finally, a University of Arkansas for Medical Sciences' BioVentures company is preparing to have its initial public offering.
Cyto Wave Technologies of San Francisco, which also has an office in Little Rock filed public documents about its plans and expects to become publicly traded in the third quarter of the year, eventually joining the Nasdaq exchange.
Cyto Wave says it has a treatment that will detect and kill cancer cells.
The company could be a huge hit for UAMS, which owns 5 percent of the firm and will receive 30 percent of any royalties the company receives.